Mercer Capital Advisers, Inc. - KYTHERA BIOPHARMACEUTICALS I ownership

Quarter-by-quarter ownership
Mercer Capital Advisers, Inc. ownership history of KYTHERA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2015$22,000
-4.3%
3000.0%0.02%
-4.8%
Q2 2015$23,000
+53.3%
3000.0%0.02%
+61.5%
Q1 2015$15,000
+50.0%
3000.0%0.01%
+44.4%
Q4 2014$10,0003000.01%
Other shareholders
KYTHERA BIOPHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
AlpInvest Partners B.V. 33,271$1,277,0004.55%
Palo Alto Investors LP 949,959$36,450,0002.71%
Redmile Group, LLC 560,356$21,501,0002.61%
SENZAR ASSET MANAGEMENT, LLC 124,900$4,792,0001.83%
Aureus Asset Management, LLC 152,662$5,858,0001.46%
PFM Health Sciences, LP 952,715$36,556,0000.73%
REGENTATLANTIC CAPITAL LLC 176,454$6,771,0000.63%
Polar Capital LLP 519,398$19,927,0000.42%
FNY Managed Accounts LLC 2,500$95,925,0000.35%
Partner Investment Management, L.P. 36,173$1,388,0000.28%
View complete list of KYTHERA BIOPHARMACEUTICALS I shareholders